Volume 14, Number 1—January 2008
International Polar Year
Dissemination of Multidrug-Resistant Bacteria into the Arctic
We show that Escherichia coli isolates originating from Arctic birds carry antimicrobial drug resistance determinants. This finding implies that dissemination of drug-resistant bacteria is worldwide. Resistance genes can be found even in a region where no selection pressure for resistance development exists.
Bacteria display a unique ability to adapt to changes in their environment and to develop mechanisms to protect themselves against toxic compounds. Their ability to develop resistance mechanisms to antimicrobial drugs has assumed catastrophic proportions, rendering more and more infections difficult or impossible to treat (1). Most reports suggest that the main force behind emergence of drug resistance is the use and misuse of antimicrobial drugs during the past few decades, but there is also evidence for the epidemic spread of drug-resistant bacteria as a contributing factor (2).
We investigated bacteria from a region considered to be one of the last outposts of wilderness, the Arctic, with the belief that in this region human influence on the ecology of antimicrobial resistance would be minimal. Antimicrobial drug resistance in Escherichia coli isolated on site from fecal or cloacal swabs of Arctic birds was studied.
During the Beringia expedition organized by the Swedish Polar Research Secretariat in 2005, fecal or cloacal samples were collected from 97 birds in 3 geographic regions: northeastern Siberia; Point Barrow, Alaska, USA (71º30′N, 156º78′W); and northern Greenland. Samples were transported in a swab-transport system to a laboratory on the expedition ship. Upon arrival, the samples were immediately cultured, and single colonies of enterobacteria were isolated on blood agar plates (3). One isolate of E. coli was selected from each sample and stored at –70°C for further analysis. Susceptibility to 17 antimicrobial drugs was determined by using disk diffusion with disks on Iso-Sensitest agar (Oxoid, Basingstoke, UK) in accordance with the recommendations of the Swedish Reference Group for Antibiotics (4). MIC determinations were performed by using the E-test (AB Biodisk, Solna, Sweden) on Iso-Sensitest agar. All bacteria were tested against the following antimicrobial drugs: ampicillin, cefadroxil, cefuroxime, cefpodoxime (to screen for E. coli with extended-spectrum β-lactamases), chloramphenicol, ciprofloxacin, fosfomycin-trometamol, gentamicin, imipenem, mecillinam, nalidixic acid, nitrofurantoin, streptomycin, sulfamethoxazole, tetracycline, trimethoprim, and tigecycline.
Clonal diversity of the 97 isolates was assessed by using a commercial typing system, the PhenePlate (PhP) system (PhPlate Microplate Techniques AB, Stockholm, Sweden). This system uses results of 11 biochemical reactions in a microplate to obtain a biochemical fingerprint of each tested isolate and has been used for typing of E. coli (5,6). Compared with traditional qualitative biochemical testing where the results are read once, PhP typing is based on several readings and thereby includes dynamics of the reaction in the analysis. PhP typing was performed as described with 2 modifications: 1 of the 11 reagents, melabionate, was replaced with raffinose, and E. coli reference strain ATCC 25922 was used as a positive control (6). Biochemical fingerprints obtained were compared with each other, and similarity was calculated by using PhPWIN4 software (6). PhP types with >2 isolates with the same biochemical fingerprint were designated as common types (CTs); types with 1 isolate, which represented rare or unique clones, were designated as single (Si) types.
E. coli isolates from Arctic birds carried antimicrobial drug resistance determinants; among 17 antimicrobial drugs tested, resistance to 14 was detected. Resistance was observed in 8 isolates, 4 of which displayed resistance to >4 drugs (Table), and occurred most often to ampicillin, sulfamethoxazole, trimethoprim, chloramphenicol, and tetracycline. Two resistant isolates displayed isolated fosfomycin resistance with MIC values of 256 mg/L and 1,024 mg/L. No resistance to gentamicin, imipenem, or tigecycline was observed.
PhP typing divided the 97 isolates into 11 CTs (CT1–CT11) and 34 Si types (Appendix Table [PDF - 15 KB - 2 pages]). The 3 most frequent CTs were CT3, CT2, and CT5, which contained 29, 9, and 5 isolates, respectively. Among the isolates from Lorino, Siberia (65º39′N, 172º15′W), (n = 13), Si types were most common (n = 5). Likewise, among isolates from Novo Chaplino, Siberia (64º70′N, 173º00′W) (n = 33), Si types (n = 19) predominated. In contrast, only 2 Si types were found among isolates from Kolyuchin, Siberia (67º04′N, 173º21′W) (n = 29). Most of these isolates (n = 18) were defined as CT3. Six of the 11 CTs were restricted to 1 sample site: CT1 at Lorino, CT6 at Novo Chaplino, CT7 at Kolyuchin, CT9 and CT10 at Wrangel Island (70º55′N, 179º29′W), and CT11 at Thule, Greenland (76º32′N, 68º44′W). Among the 8 drug-resistant isolates, 1 was CT3 and 2 were CT5; the other 5 were defined as Si types (Table).
Antimicrobial drug resistance in E. coli isolated from wild birds has been described (7,8). A high frequency of E. coli isolates from migratory Canada geese sampled on the eastern shore of Maryland in the United States were resistant to penicillin G, ampicillin, cephalothin, and sulfathiazole (8). Similarly, a high prevalence of antimicrobial drug–resistant E. coli isolated from black-headed gulls in the Czech Republic has been observed (7).
There are several explanations for antimicrobial drug resistance in the normal microbiota of Arctic birds. First, resistance may develop de novo through spontaneous mutation(s) (9). Second, resistance can be acquired by horizontal gene transfer from other microbes; many bacteria and fungi constitute natural sources of drug resistance genes and may serve as reservoirs in the environment (10). Third, bacteria with antimicrobial drug resistance could be imported into the region either by migratory birds or through human refuse (food, excretions) from fishermen, settlers, and prospectors in the area. The region around the Bering Strait constitutes the breeding ground of a large number of waterfowl, geese, and shorebirds. Although many of these species are largely confined to one side of the Bering Strait, other species pass through both continents during migration or occasionally wander across the strait (11). Moreover, bird species that spend the winter in up to 6 different continents can be found in this area (11). Thus, migratory birds that have acquired drug-resistant bacteria during wintering or stops at lower latitudes before migrating to the Arctic provide a potential explanation for introduction of drug resistance into this region. The fact that 1 isolate from a juvenile Western sandpiper sampled far from human settlements on the tundra had resistance to cefadroxil, cefuroxime, and cefpodoxime, a resistance pattern commonly seen in clinical isolates, supports the theory of introduction by migration and transfer of bacteria between birds.
To the best of our knowledge, the most remote and isolated environment investigated for drug-resistant bacteria is the Bolivian community of 130 Guaraní Indians, as described by Bartoloni et al. (12). This community is located at an altitude of ≈1,700 m and can only be reached by a 3-hour steep climb. Nevertheless, high carriage rates of drug-resistant commensal E. coli were found in this community, although exposure to antimicrobial drugs in the area had been limited. Similarly, antimicrobial drug–resistant bacteria in wild animals with little or no contact with human settings has been reported (13,14). These findings and those of our study suggest that commensal bacteria in humans and animals constitute hidden reservoirs of antimicrobial drug resistance (15). A possible explanation for the unexpectedly high carriage rate of drug-resistant E. coli in the Indian community in Bolivia is the importation of drug-resistant isolates by migratory birds.
We have shown that antimicrobial drug resistance genes are present in 1 of the most remote areas on Earth, the Arctic. Resistant as well as multiresistant isolates of E. coli were detected in the normal flora of Arctic birds. This finding highlights the unique nature of bacterial adaptation and the complexity of dissemination of antimicrobial drug resistance. To fully understand the extent of environmental and commensal reservoirs of resistance, studies of antimicrobial drug resistance in different habitats are warranted.
Dr Sjölund is a researcher with the National Antimicrobial Resistance Surveillance Team at the Centers for Disease Control and Prevention in Atlanta, Georgia. Her research interests include characterization of drug-resistant bacteria, mechanisms of resistance, and studies of the biological cost of drug resistance.
This work was supported logistically by the Swedish Polar Secretariat and financially by the Swedish Research Council FORMAS (2005-2051), the Swedish Research Council (2004-5489), the European Union, the Health Research Council of Southeast Sweden, and the Medical Faculty of Umeå University.
- Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992;257:1050–5.
- Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis. 2003;36(Suppl 1):S11–23.
- Melhus Å. Juhlin’s medium, a selective and differential medium for gram-negative rods. Med Microbiol Lett. 1996;5:74–81.
- Kahlmeter G. The Swedish Reference Group for Antibiotics (SRGA) and its Subcommittee on Methodology (SRGA-M), 2007 [cited 2007 Oct 17]. Available from http://www.srga.org
- Kuhn IBB. Biochemical fingerprinting of Escherichia coli: a simple method for epidemiological investigations. J Microbiol Methods. 1985;3:159–70.
- Landgren M, Oden H, Kuhn I, Osterlund A, Kahlmeter G. Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries. J Antimicrob Chemother. 2005;55:928–37.
- Dolejska M, Cizek A, Literak I. High prevalence of antimicrobial-resistant genes and integrons in Escherichia coli isolates from black-headed gulls in the Czech Republic. J Appl Microbiol. 2007;103:11–9.
- Middleton JH, Ambrose A. Enumeration and antibiotic resistance patterns of fecal indicator organisms isolated from migratory Canada geese (Branta canadensis). J Wildl Dis. 2005;41:334–41.
- Martinez JL, Baquero F. Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother. 2000;44:1771–7.
- Maiden MC. Horizontal genetic exchange, evolution, and spread of antibiotic resistance in bacteria. Clin Infect Dis. 1998;27(Suppl 1):S12–20.
- Winker K, McCracken KG, Gibson DD, Pruett CL, Meier R, Huettmann F, Movements of birds and avian influenza from Asia into Alaska. Emerg Infect Dis. 2007;13:547–52.
- Bartoloni A, Bartalesi F, Mantella A, Dell’Amico E, Roselli M, Strohmeyer M, High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption. J Infect Dis. 2004;189:1291–4.
- Gilliver MA, Bennett M, Begon M, Hazel SM, Hart CA. Antibiotic resistance found in wild rodents. Nature. 1999;401:233–4.
- Lillehaug A, Bergsjo B, Schau J, Bruheim T, Vikoren T, Handeland K. Campylobacter spp., Salmonella spp., verocytotoxic Escherichia coli, and antibiotic resistance in indicator organisms in wild cervids. Acta Vet Scand. 2005;46:23–32.
- Andremont A. Commensal flora may play key role in spreading antibiotic resistance. American Society for Microbiology News. 2003;69:601–7.
- Table. Antimicrobial drug resistance phenotypes in 8 Escherichia coli isolates from Arctic birds
- Appendix Table. Origin and PhenePlate types of 97 Escherichia coli isolates from Arctic birds 15 KB
Suggested citation for this article: Sjölund M, Bonnedahl J, Hernandez J, Bengtsson S, Cederbrant G, Pinhassi J, et al. Dissemination of multidrug-resistant bacteria into the Arctic. Emerg Infect Dis [serial on the Internet]. 2008 Jan [date cited]. Available from http://wwwnc.cdc.gov/eid/article/14/1/07-0704
Please use the form below to submit correspondence to the authors or contact them at the following address:
Björn Olsen, Section of Infectious Diseases, Department of Medical Sciences, Uppsala University Hospital, SE-751 85 Uppsala, Sweden;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 08, 2010
- Page last updated: July 08, 2010
- Page last reviewed: July 08, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)